Over-the-Counter (OTC) Pet Medication Market Report 2026

The over-the-counter (otc) pet medication market size has grown strongly in recent years. It will grow from $9.15 billion in 2025 to $9.67 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to limited availability of veterinary prescriptions, growing pet population, increasing prevalence of common pet ailments, rising awareness of pet health, traditional retail channels dominance.

The over-the-counter (otc) pet medication market size is expected to see strong growth in the next few years. It will grow to $12.16 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to expansion of e-commerce for pet medications, increasing demand for preventive care products, growth in tech-enabled pet health monitoring, rising consumer spending on pet wellness, adoption of personalized supplements and treatments. Major trends in the forecast period include rising adoption of otc pet medications, integration of smart pet health devices, increasing awareness about preventive pet care, expansion of online pet pharmacies, growth in personalized pet nutrition and supplements.

The rising pet ownership is expected to drive growth in the over-the-counter (OTC) pet medication market in the coming years. Pet ownership involves the legal and ethical responsibility of caring for and managing a domesticated animal as a companion. Increasing pet ownership is fueled by factors such as companionship and emotional support, higher living standards, urbanization, changing family structures, and greater awareness of the health and wellness benefits of having pets. OTC pet medications make caring for pets more convenient and accessible by providing affordable, easily available solutions for common health issues. For instance, in March 2024, UK Pet Food, a UK-based trade association, reported that approximately 17.2 million households, representing 60% of UK homes, owned one or more of the nation’s 36 million pets. Therefore, the growing number of pet owners is boosting the OTC pet medication market.

Companies in this market are focusing on innovative product development to maintain competitiveness, such as the introduction of monoclonal antibody treatments. Monoclonal antibodies are identical immune cells cloned from a single parent cell, designed to target specific disease mechanisms. For example, in October 2023, Zoetis Inc., a US-based pharmaceutical company, launched Bedinvetmab injections and Oclacitinib chewable tablets, both approved by the US Food and Drug Administration (FDA). Oclacitinib chewable tablets are the first FDA-approved chewable treatment in the US for managing pruritus associated with allergic and atopic dermatitis in dogs aged one year or older, offering a novel solution for allergic itch and inflammation in canines. These medications are now available through veterinary prescriptions in the United States.

In April 2023, PetMed Express Inc., a US-based online pharmacy, acquired PetCareRx Inc. for an undisclosed amount. This acquisition strengthens PetMed Express’s position in the online pet pharmacy market by expanding its product range, increasing its customer base, and improving operational integration and customer engagement. PetCareRx Inc., based in the US, provides a variety of OTC pet medications and wellness products.

Major companies operating in the over-the-counter (otc) pet medication market are Zoetis Inc, Elanco Animal Health Incorporated, Virbac S A, PetIQ Holdings LLC, Vetoquinol S A, Bimeda Inc, Med‑Vet International Inc, Sergeant’s Pet Care Products Inc, Advecta, Zesty Paws, Durvet Inc, Pet King Brands, Animax Ltd, PetArmor, Dechra Pharmaceuticals, Beaphar, Innovacyn, Nutramax Laboratories, Vet’s Best, Vetriscience Laboratories, TropiClean, Hartz Mountain Corporation, Pet Honesty, Nutri‑Vet, NaturVet, Pet Naturals of Vermont, Grizzly Pet Products.

North America was the largest region in the over-the-counter (OTC) pet medication market in 2025. The regions covered in the over-the-counter (otc) pet medication market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the over-the-counter (otc) pet medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the OTC pet medication market by increasing import costs of medications, supplements, and smart pet health devices. Drug and pharmacy stores, pet specialty retailers, and online channels in regions such as north america, europe, and asia-pacific are most impacted due to reliance on imported products. While tariffs have slightly increased prices, they have also encouraged local manufacturing, innovation in cost-effective formulations, and reduced dependency on imports.

The over-the-counter (otc) pet medication market research report is one of a series of new reports that provides over-the-counter (otc) pet medication market statistics, including over-the-counter (otc) pet medication industry global market size, regional shares, competitors with a over-the-counter (otc) pet medication market share, detailed over-the-counter (otc) pet medication market segments, market trends and opportunities, and any further data you may need to thrive in the over-the-counter (otc) pet medication industry. This over-the-counter (otc) pet medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Over-the-counter (OTC) pet medications are treatments and medicines for pets that can be purchased without a veterinarian’s prescription. These products are available in retail stores, online platforms, and pet supply outlets and are used for common health issues and preventive care, including flea and tick prevention, dental care, supplements, and minor skin treatments.

The main types of OTC pet medications include flea and tick control, wormers and dewormers, dental care products, nutritional supplements, skin and coat care, pain and allergy relief, and other medications. Flea and tick control products prevent and eliminate infestations through topical treatments, collars, sprays, or oral medications. These medications are intended for various pets, including dogs, cats, birds, fish, reptiles, and others, and are available in forms such as chews and treats, capsules, ointments, sprays, and more. They are distributed through channels like drug and pharmacy stores, pet specialty stores, veterinary clinics and hospitals, online retailers, and other outlets.

The over-the-counter (OTC) pet medication market consists of sales of heartworm preventatives, digestive aids and probiotics, allergy relief medications, and worming medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.